These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21474799)

  • 1. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set.
    Mlynash M; Lansberg MG; De Silva DA; Lee J; Christensen S; Straka M; Campbell BC; Bammer R; Olivot JM; Desmond P; Donnan GA; Davis SM; Albers GW;
    Stroke; 2011 May; 42(5):1270-5. PubMed ID: 21474799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.
    Parsons MW; Christensen S; McElduff P; Levi CR; Butcher KS; De Silva DA; Ebinger M; Barber PA; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1214-25. PubMed ID: 20087363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.
    Rao V; Christensen S; Yennu A; Mlynash M; Zaharchuk G; Heit J; Marks MP; Lansberg MG; Albers GW
    Stroke; 2019 Mar; 50(3):626-631. PubMed ID: 30727840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2.
    Wheeler HM; Mlynash M; Inoue M; Tipirneni A; Liggins J; Zaharchuk G; Straka M; Kemp S; Bammer R; Lansberg MG; Albers GW;
    Stroke; 2013 Mar; 44(3):681-5. PubMed ID: 23390119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy.
    Inoue M; Mlynash M; Straka M; Lansberg MG; Zaharchuk G; Bammer R; Albers GW
    Stroke; 2012 Sep; 43(9):2494-6. PubMed ID: 22811464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the perfusion-diffusion mismatch hypothesis.
    Butcher KS; Parsons M; MacGregor L; Barber PA; Chalk J; Bladin C; Levi C; Kimber T; Schultz D; Fink J; Tress B; Donnan G; Davis S;
    Stroke; 2005 Jun; 36(6):1153-9. PubMed ID: 15914768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Early Reperfusion Criteria in Acute Ischemic Stroke.
    Ozenne B; Cho TH; Mikkelsen IK; Hermier M; Ribe L; Thomalla G; Pedraza S; Baron JC; Roy P; Berthezène Y; Nighoghossian N; Østergaard L; Maucort-Boulch D
    J Neuroimaging; 2015; 25(6):952-8. PubMed ID: 25940773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study.
    Lansberg MG; Lee J; Christensen S; Straka M; De Silva DA; Mlynash M; Campbell BC; Bammer R; Olivot JM; Desmond P; Davis SM; Donnan GA; Albers GW
    Stroke; 2011 Jun; 42(6):1608-14. PubMed ID: 21493916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score (DWI-ASPECTS) and Ischemic Core Volume to Determine the Malignant Profile in Acute Stroke.
    Yoshimoto T; Inoue M; Yamagami H; Fujita K; Tanaka K; Ando D; Sonoda K; Kamogawa N; Koga M; Ihara M; Toyoda K
    J Am Heart Assoc; 2019 Nov; 8(22):e012558. PubMed ID: 31698986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy.
    Toyoda K; Inoue M; Yoshimura S; Yamagami H; Sasaki M; Fukuda-Doi M; Kimura K; Asakura K; Miwa K; Kanzawa T; Ihara M; Kondo R; Shiozawa M; Ohtaki M; Kamiyama K; Itabashi R; Iwama T; Aoki J; Minematsu K; Yamamoto H; Koga M;
    Stroke; 2021 Jan; 52(1):12-19. PubMed ID: 33297866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE).
    Olivot JM; Mlynash M; Thijs VN; Purushotham A; Kemp S; Lansberg MG; Wechsler L; Gold GE; Bammer R; Marks MP; Albers GW
    Stroke; 2009 Oct; 40(10):3245-51. PubMed ID: 19679845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Mismatch Concepts for Magnetic Resonance Imaging-Guided Thrombolysis in Unknown Onset Stroke.
    Scheldeman L; Wouters A; Boutitie F; Dupont P; Christensen S; Cheng B; Ebinger M; Endres M; Fiebach JB; Gerloff C; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thijs V; Thomalla G; Lemmens R;
    Ann Neurol; 2020 Jun; 87(6):931-938. PubMed ID: 32227638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.
    Simonsen CZ; Madsen MH; Schmitz ML; Mikkelsen IK; Fisher M; Andersen G
    Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion.
    Lansberg MG; Thijs VN; Bammer R; Olivot JM; Marks MP; Wechsler LR; Kemp S; Albers GW
    Stroke; 2008 Sep; 39(9):2491-6. PubMed ID: 18635861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.
    Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Yavagal DR; Saver JL
    Stroke; 2015 Oct; 46(10):2786-94. PubMed ID: 26316344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.